Funding & Deals Sep 22, 2026 · 1 min read · 15,295 views

UK government committees call for probe into US pharma deal

Isabella Hart

Editorial · Sep 22, 2026

Six UK parliamentary committees ask the National Audit Office to probe the cost of the £1B UK-US pharma deal and its NHS impact

← Previous

Ziopharm rebrands to Alaunos, closes Boston office with new CEO at the reins

Cue Biopharma's potential Xolair challenger passes Phase 2 chronic hives trial

Related Reading

A Parkinson's biotech debut, fundraising campaign and licensing deal

Sep 28, 2026

Updated: Electra says $350M IPO will help it become a commercial biotech

Sep 27, 2026

Iambic releases next version of its Enchant model, signs deal with AbbVie

Sep 25, 2026